{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "interpro:IPR001314",
      "entity_text" : "chymotrypsin",
      "entity_type" : "family"
    },
    "participant_a" : [ {
      "in_model" : true,
      "identifier" : "uaz:UAZ15198",
      "entity_text" : "epoxomicin",
      "entity_type" : "protein"
    }, {
      "in_model" : true,
      "identifier" : "be:Proteasome",
      "entity_text" : "proteasome",
      "entity_type" : "protein"
    } ],
    "hypothesis_information" : false
  },
  "verbose_text" : "MG132 blocks the proteolytic activity of the 26S proteasome complex by inhibiting the degradation of ubiquitin conjugated proteins, and epoxomicin binds the catalytic subunits of the proteasome potently inhibiting its chymotrypsin like activity.",
  "reading_complete" : "2020-08-08T16:34:16Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T16:30:33Z",
  "trigger" : "inhibiting",
  "evidence" : [ "epoxomicin binds the catalytic subunits of the proteasome potently inhibiting its chymotrypsin" ],
  "pmc_id" : "6686882",
  "score" : 0
}